{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:57:19Z","timestamp":1793750239457,"version":"4.6.1"},"reference-count":119,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:p>Sickle cell disease (SCD) is a group of complex genetic disorders of hemoglobin with multisystem manifestations. The scope of this clinical report is such that in-depth recommendations for management of all complications is not possible. Rather, the authors present an overview focused on the practical management of children and adolescents with SCD and the complications that are of particular relevance to pediatric primary care providers. References with detailed commentary provide further information. Timely and appropriate treatment of acute illness is critical, because life-threatening complications may develop rapidly. Specialized comprehensive medical care decreases morbidity and mortality during childhood. The provision of comprehensive care is a time-intensive endeavor that includes ongoing patient and family education, periodic comprehensive evaluations and other disease-specific health maintenance services, nursing support, psychosocial care, and genetic counseling. Ideally, this care includes comanagement by the pediatrician or other pediatric primary care provider and a team of specialist SCD experts: Hematologist, other pediatric specialists, advanced practice providers, nurse specialists, social workers, patient navigators, and educational liaisons.<\/jats:p>","DOI":"10.1542\/peds.2024-066842","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T08:06:16Z","timestamp":1721635576000},"source":"Crossref","is-referenced-by-count":29,"title":["Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report"],"prefix":"10.1542","volume":"154","author":[{"given":"Amber M.","family":"Yates","sequence":"first","affiliation":[{"name":"aDivision of Pediatric Hematology\/Oncology, Department of Pediatrics, Baylor College of Medicine and Texas Children\u2019s Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Aygun","sequence":"additional","affiliation":[{"name":"bNorthwell, New Hyde Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Nuss","sequence":"additional","affiliation":[{"name":"cCenter for Cancer and Blood Disorders, Children\u2019s Hospital Colorado, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora R.","family":"Rogers","sequence":"additional","affiliation":[{"name":"dDivision of Pediatric Hematology\/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center and Children\u2019s Heath, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Section on Hematology\/Oncology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Wetmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayson","family":"Stoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Warwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtiza","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eneida A.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy J.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY\/ONCOLOGY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Hastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"DiPaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"issue":"9","key":"2024080102534014000_B1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/pbc.24557","article-title":"Sickle cell disease related mortality in the United States (1999\u20132009)","volume":"60","author":"Hamideh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"17","key":"2024080102534014000_B2","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2024080102534014000_B3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajh.24235","article-title":"Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years","volume":"91","author":"Chaturvedi","year":"2016","journal-title":"Am J Hematol"},{"issue":"6","key":"2024080102534014000_B4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.pcl.2013.09.006","article-title":"Sickle cell disease in childhood: from newborn screening through transition to adult medical care","volume":"60","author":"Quinn","year":"2013","journal-title":"Pediatr Clin North Am"},{"issue":"6","key":"2024080102534014000_B5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.md.0000189089.45003.52","article-title":"Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients","volume":"84","author":"Powars","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"2024080102534014000_B6","unstructured":"National Heart, Lung, and Blood Institute. Evidence-based management of sickle cell disease: expert panel report, 2014. Available at: https:\/\/www.nhlbi.nih.gov\/health-topics\/evidence-based-management-sickle-cell-disease. Accessed February 23, 2024"},{"issue":"1","key":"2024080102534014000_B7","doi-asserted-by":"crossref","first-page":"e29961","DOI":"10.1002\/pbc.29961","article-title":"Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center","volume":"70","author":"Hulbert","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024080102534014000_B8","first-page":"280","article-title":"Practice patterns for addressing developmental-behavioral concerns in sickle cell specialty care","volume":"11","author":"Schlenz","year":"2023","journal-title":"Clin Pract Pediatr Psychol"},{"issue":"16","key":"2024080102534014000_B9","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"issue":"20","key":"2024080102534014000_B10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words\u2013racism and sickle cell disease","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"2024080102534014000_B11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing health care disparities in sickle cell disease: a review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"issue":"6","key":"2024080102534014000_B12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.hoc.2022.08.008","article-title":"Structural racism and impact on sickle cell disease. Sickle lives matter","volume":"36","author":"Smith","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2024080102534014000_B13","doi-asserted-by":"crossref","first-page":"e2023061585","DOI":"10.1542\/peds.2023-061585","article-title":"Explicitly addressing implicit bias on inpatient rounds: student and faculty reflections","volume":"151","author":"Carter","year":"2023","journal-title":"Pediatrics"},{"issue":"2","key":"2024080102534014000_B14","doi-asserted-by":"crossref","first-page":"e20171489","DOI":"10.1542\/peds.2017-1489","article-title":"Guiding principles for team-based pediatric care","volume":"140","author":"Katkin","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"2024080102534014000_B15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/003335491312800206","article-title":"Mortality rates and age at death from sickle cell disease: United States, 1979\u20132005","volume":"128","author":"Lanzkron","year":"2013","journal-title":"Public Health Rep"},{"issue":"11","key":"2024080102534014000_B16","doi-asserted-by":"crossref","first-page":"e1915374","DOI":"10.1001\/jamanetworkopen.2019.15374","article-title":"Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease","volume":"2","author":"Lubeck","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"13","key":"2024080102534014000_B17","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/bloodadvances.2022009202","article-title":"Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries","volume":"7","author":"Jiao","year":"2023","journal-title":"Blood Adv"},{"issue":"10091","key":"2024080102534014000_B18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2024080102534014000_B19","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.amepre.2016.02.019","article-title":"Newborn screening programs and sickle cell disease: a public health services and systems approach","volume":"51","author":"Minkovitz","year":"2016","journal-title":"Am J Prev Med"},{"issue":"1","key":"2024080102534014000_B20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1542\/peds.2007-3021","article-title":"Newborn screening expands: recommendations for pediatricians and medical homes\u2013implications for the system","volume":"121","author":"American Academy of Pediatrics Newborn Screening Authoring Committee","year":"2008","journal-title":"Pediatrics"},{"key":"2024080102534014000_B21","unstructured":"American College of Medical Genetics. ACT sheets and algorithms: hemoglobin disorders in newborn screening. Available at: https:\/\/www.acmg.net\/ACMG\/Medical-Genetics-Practice-Resources\/ACT_Sheets_and_Algorithms.aspx. Accessed February 23, 2024"},{"key":"2024080102534014000_B22","unstructured":"Centers for Disease Control and Prevention, American Society of Hematology, Sickle Cell Disease Association of America. Sickle cell trait toolkit. Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/toolkit.html. Accessed February 23, 2024"},{"key":"2024080102534014000_B23","unstructured":"Centers for Disease Control and Prevention. Sickle cell disease (SCD). Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/index.html. Accessed January 18, 2023"},{"key":"2024080102534014000_B24","unstructured":"Health Resources and Services Administration. The Innovations in Newborn Screening Interoperability Resource Center and Learning Collaborative. Available at: https:\/\/nbsinterop.org\/services. Accessed February 23, 2024"},{"issue":"3","key":"2024080102534014000_B25","doi-asserted-by":"crossref","first-page":"e2022060970","DOI":"10.1542\/peds.2022-060970","article-title":"Access to critical health information for children during emergencies: emergency information forms and beyond","volume":"151","author":"Callahan","year":"2023","journal-title":"Pediatrics"},{"key":"2024080102534014000_B26","unstructured":"Centers for Disease Control and Prevention. Complications of sickle cell disease. Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/complications.html. Accessed January 18, 2023"},{"issue":"2","key":"2024080102534014000_B27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"2024080102534014000_B28","first-page":"CD012082","article-title":"Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews","volume":"8","author":"Fortin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2024080102534014000_B29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/bjh.15846","article-title":"Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature","volume":"185","author":"Oligbu","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"2024080102534014000_B30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PEC.0000000000001569","article-title":"Practice variation in emergency department management of children with sickle cell disease who present with fever","volume":"34","author":"Eisenbrown","year":"2018","journal-title":"Pediatr Emerg Care"},{"issue":"12","key":"2024080102534014000_B31","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2024080102534014000_B32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.hoc.2018.01.014","article-title":"Key components of pain management for children and adults with sickle cell disease","volume":"32","author":"Brandow","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2024080102534014000_B33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpainsymman.2015.10.017","article-title":"Sickle cell disease: a review of nonpharmacological approaches for pain","volume":"51","author":"Williams","year":"2016","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"2024080102534014000_B34","doi-asserted-by":"crossref","first-page":"e20182218","DOI":"10.1542\/peds.2018-2218","article-title":"Improving care for sickle cell pain crisis using a multidisciplinary approach","volume":"143","author":"Balsamo","year":"2019","journal-title":"Pediatrics"},{"issue":"11","key":"2024080102534014000_B35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM199509143331104","article-title":"Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases","volume":"333","author":"Bellet","year":"1995","journal-title":"N Engl J Med"},{"issue":"4","key":"2024080102534014000_B36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ped.2017.0814","article-title":"Acute chest syndrome in children with sickle cell disease","volume":"30","author":"Jain","year":"2017","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"12","key":"2024080102534014000_B37","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/ajh.24539","article-title":"Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype","volume":"91","author":"Chaturvedi","year":"2016","journal-title":"Am J Hematol"},{"issue":"11","key":"2024080102534014000_B38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamapediatrics.2015.1915","article-title":"Racial disparities in pain management of children with appendicitis in emergency departments","volume":"169","author":"Goyal","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"5","key":"2024080102534014000_B39","doi-asserted-by":"crossref","first-page":"e20193370","DOI":"10.1542\/peds.2019-3370","article-title":"Racial and ethnic differences in emergency department pain management of children with fractures","volume":"145","author":"Goyal","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"2024080102534014000_B40","doi-asserted-by":"crossref","first-page":"e20190348","DOI":"10.1542\/peds.2019-0348","article-title":"Racial differences in sepsis recognition in the emergency department","volume":"144","author":"Raman","year":"2019","journal-title":"Pediatrics"},{"issue":"4","key":"2024080102534014000_B41","doi-asserted-by":"crossref","first-page":"e20170203","DOI":"10.1542\/peds.2017-0203","article-title":"Racial and ethnic differences in antibiotic use for viral illness in emergency departments","volume":"140","author":"Goyal","year":"2017","journal-title":"Pediatrics"},{"issue":"12","key":"2024080102534014000_B42","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s11606-014-2986-7","article-title":"Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease","volume":"29","author":"Haywood","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2024080102534014000_B43","doi-asserted-by":"crossref","first-page":"e20191765","DOI":"10.1542\/peds.2019-1765","article-title":"The impact of racism on child and adolescent health","volume":"144","author":"Trent","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"2024080102534014000_B44","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1353\/hpu.2015.0094","article-title":"The effect of structural violence on patients with SCD","volume":"26","author":"Bahr","year":"2015","journal-title":"J Health Care Poor Underserved"},{"issue":"20","key":"2024080102534014000_B45","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1182\/blood-2010-11-261834","article-title":"How I treat acute chest syndrome in children with sickle cell disease","volume":"117","author":"Miller","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2024080102534014000_B46","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ppul.25845","article-title":"Benefit of pulmonary subspecialty care for children with sickle cell disease and asthma","volume":"57","author":"Saxena","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2024080102534014000_B47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2141.2011.08999.x","article-title":"Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 pediatric patients","volume":"156","author":"Brousse","year":"2012","journal-title":"Br J Haematol"},{"issue":"2","key":"2024080102534014000_B48","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2223\/JPED.1885","article-title":"Acute splenic sequestration in a cohort of children with sickle cell anemia","volume":"85","author":"Rezende","year":"2009","journal-title":"J Pediatr (Rio J)"},{"key":"2024080102534014000_B49","doi-asserted-by":"crossref","first-page":"102374","DOI":"10.1016\/j.bcmd.2019.102374","article-title":"Prevalence and predictive factors of splenic sequestration crisis among 423 pediatric patients with sickle cell disease in Tunisia","volume":"80","author":"Ben Khaled","year":"2020","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"2024080102534014000_B50","doi-asserted-by":"crossref","first-page":"e0192710","DOI":"10.1371\/journal.pone.0192710","article-title":"Causes of death and early life determinants of survival in homozygous sickle cell disease: the Jamaican cohort study from birth","volume":"13","author":"Serjeant","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"2024080102534014000_B51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1535370216636723","article-title":"Original research: parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era","volume":"241","author":"Hankins","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"2024080102534014000_B52","first-page":"562","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021","edition":"32nd ed"},{"issue":"7","key":"2024080102534014000_B53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease","volume":"127","author":"DeBaun","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2024080102534014000_B54","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"key":"2024080102534014000_B55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2019.02.018","article-title":"Sickle cell disease and stroke","volume":"95","author":"Hirtz","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"17","key":"2024080102534014000_B56","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2024080102534014000_B57","first-page":"CD003146","article-title":"Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease","volume":"7","author":"Estcourt","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024080102534014000_B58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"issue":"10019","key":"2024080102534014000_B59","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","article-title":"Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicenter, open-label, phase 3, noninferiority trial","volume":"387","author":"Ware","year":"2016","journal-title":"Lancet"},{"issue":"14","key":"2024080102534014000_B60","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2015-10-675231","article-title":"Long-term treatment follow-up of children with sickle cell disease monitored with abnormal transcranial Doppler velocities","volume":"127","author":"Bernaudin","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2024080102534014000_B61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1401731","article-title":"Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia","volume":"371","author":"DeBaun","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2024080102534014000_B62","doi-asserted-by":"crossref","first-page":"e0201860","DOI":"10.1371\/journal.pone.0201860","article-title":"Enuresis in children and adolescents with sickle cell anemia is more frequent and substantially different from the general population","volume":"13","author":"Esezobor","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"2024080102534014000_B63","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"2024080102534014000_B64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03630269.2018.1452760","article-title":"Prevalence and characteristics of priapism in sickle cell disease","volume":"42","author":"Arduini","year":"2018","journal-title":"Hemoglobin"},{"issue":"6","key":"2024080102534014000_B65","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2024080102534014000_B66","first-page":"CDOO4198","article-title":"Treatments for priapism in boys and men with sickle cell disease","volume":"2020","author":"Chinegwundoh","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024080102534014000_B67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JU.0000000000002767","article-title":"The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and nonischemic priapism: an AUA\/SMSNA Guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"key":"2024080102534014000_B68","unstructured":"Noronha\u2008SA, Lanzkron\u2008S. American Society of Hematology. Health maintenance and management of chronic complications of sickle cell disease. A pocket guide for the clinician. Available at: http:\/\/ashpocketguides.hematology.org\/?&_ga=2.158481983.447722123.1674071813-1347764106.1670560597#\/app\/guides\/3\/pages\/. Accessed February 23, 2024"},{"issue":"7","key":"2024080102534014000_B69","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ophtha.2019.02.023","article-title":"Prevalence and onset of pediatric sickle cell retinopathy","volume":"126","author":"Li","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"2024080102534014000_B70","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1037\/amp0000042","article-title":"Neurocognitive deficits in children with chronic health conditions","volume":"72","author":"Compas","year":"2017","journal-title":"Am Psychol"},{"issue":"4","key":"2024080102534014000_B71","doi-asserted-by":"crossref","first-page":"e2023061451","DOI":"10.1542\/peds.2023-061451","article-title":"2023 recommendations for preventive pediatric health care","volume":"151","author":"Committee on Practice and Ambulatory Medicine","year":"2023","journal-title":"Pediatrics"},{"issue":"2","key":"2024080102534014000_B72","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/pbc.24176","article-title":"Health-related quality of life in sickle cell disease: past, present, and future","volume":"59","author":"Panepinto","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"2024080102534014000_B73","author":"National Academies of Sciences, Engineering, and Medicine","year":"2020"},{"key":"2024080102534014000_B74","doi-asserted-by":"crossref","first-page":"33616","DOI":"10.3402\/meo.v21.33616","article-title":"Translating sickle cell guidelines into practice for primary care providers with Project ECHO","volume":"21","author":"Shook","year":"2016","journal-title":"Med Educ Online"},{"issue":"2","key":"2024080102534014000_B75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jwh.2018.7147","article-title":"Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease","volume":"28","author":"Sharma","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"2024080102534014000_B76","doi-asserted-by":"crossref","first-page":"174","DOI":"10.14423\/SMJ.0000000000000949","article-title":"Contraceptive methods and the impact of menstruation on daily functioning in women with sickle cell disease","volume":"112","author":"Day","year":"2019","journal-title":"South Med J"},{"issue":"2","key":"2024080102534014000_B77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","article-title":"Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia","volume":"102","author":"Pegelow","year":"1997","journal-title":"Am J Med"},{"issue":"3","key":"2024080102534014000_B78","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"2024080102534014000_B79","doi-asserted-by":"crossref","first-page":"e20193449","DOI":"10.1542\/peds.2019-3449","article-title":"Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening","volume":"145","author":"Lipkin","year":"2020","journal-title":"Pediatrics"},{"key":"2024080102534014000_B80","first-page":"75","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021","edition":"32nd ed"},{"issue":"39","key":"2024080102534014000_B81","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm7239a5","article-title":"ACIP updates: recommendations for the use of 20-valent pneumococcal conjugate vaccine in children\u2013United States, 2023","volume":"72","author":"Centers for Disease Control and Prevention","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024080102534014000_B82","first-page":"31","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021","edition":"32nd ed"},{"issue":"1","key":"2024080102534014000_B83","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm7301a2","article-title":"Advisory Committee on Immunization Practices-recommended immunization schedule for children and adolescents aged 18 years or younger\u2013United States, 2024","volume":"73","author":"Wodi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024080102534014000_B84","unstructured":"Centers for Disease Control and Prevention. PneumoRecs VaxAdvisor mobile app for vaccine providers. Available at: https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/pneumoapp.html. Accessed February 23, 2024"},{"key":"2024080102534014000_B85","first-page":"724","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021","edition":"32nd ed"},{"key":"2024080102534014000_B86","first-page":"528","volume-title":"Red Book: 2021 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2021","edition":"32nd ed"},{"issue":"8","key":"2024080102534014000_B87","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V85.8.2238.bloodjournal8582238","article-title":"Functional asplenia in hemoglobin SC disease","volume":"85","author":"Lane","year":"1995","journal-title":"Blood"},{"issue":"3","key":"2024080102534014000_B88","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-3476(95)70062-5","article-title":"Bacteremia in children with sickle hemoglobin C disease and sickle beta(+)-thalassemia: is prophylactic penicillin necessary?","volume":"127","author":"Rogers","year":"1995","journal-title":"J Pediatr"},{"issue":"3","key":"2024080102534014000_B89","first-page":"CD011130","article-title":"Folate supplementation in people with sickle cell disease","volume":"3","author":"Dixit","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2024080102534014000_B90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"20","key":"2024080102534014000_B91","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"5","key":"2024080102534014000_B92","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I\/II trial","volume":"94","author":"Kinney","year":"1999","journal-title":"Blood"},{"issue":"9778","key":"2024080102534014000_B93","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","article-title":"Hydroxycarbamide in very young children with sickle-cell anemia: a multicenter, randomized, controlled trial (BABY HUG)","volume":"377","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"2024080102534014000_B94","first-page":"S6","article-title":"Follow up of hydroxyurea (HU) in infants with sickle cell anemia (SCA): findings from BABY HUG studies","volume":"67","author":"Rogers","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"2024080102534014000_B95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"2024080102534014000_B96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"2024080102534014000_B97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A Phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"2024080102534014000_B98","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"issue":"18","key":"2024080102534014000_B99","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/bloodadvances.2021004394C","article-title":"American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation","volume":"5","author":"Kanter","year":"2021","journal-title":"Blood Adv"},{"key":"2024080102534014000_B100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-med-041817-125507","article-title":"Emerging genetic therapy for sickle cell disease","volume":"70","author":"Orkin","year":"2019","journal-title":"Annu Rev Med"},{"key":"2024080102534014000_B101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12888-015-0461-6","article-title":"Depression and quality of life in children with sickle cell disease: the effect of social support","volume":"15","author":"Sehlo","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"4","key":"2024080102534014000_B102","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0898010115619055","article-title":"The role of spirituality and religiosity in persons living with sickle cell disease: a review of the literature","volume":"34","author":"Clayton-Jones","year":"2016","journal-title":"J Holist Nurs"},{"issue":"3","key":"2024080102534014000_B103","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1353\/hpu.2011.0087","article-title":"Understanding the social networks of parents of children with sickle cell disease","volume":"22","author":"Vaughn","year":"2011","journal-title":"J Health Care Poor Underserved"},{"issue":"6","key":"2024080102534014000_B104","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjh.17658","article-title":"Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease","volume":"194","author":"Pecker","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"2024080102534014000_B105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jadohealth.2021.06.008","article-title":"Provider attitudes, preferences, and practices regarding sexual and reproductive health for adolescents and young adults with sickle cell disease","volume":"69","author":"Leroy-Melamed","year":"2021","journal-title":"J Adolesc Health"},{"issue":"10","key":"2024080102534014000_B106","doi-asserted-by":"crossref","first-page":"e29877","DOI":"10.1002\/pbc.29877","article-title":"Pediatric hematology providers\u2019 contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey","volume":"69","author":"Askew","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2024080102534014000_B107","unstructured":"Centers for Disease Control and Prevention. US medical eligibility criteria (US MEC) for contraceptive use, 2016. Available at: https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/mec\/summary.html. Accessed February 23, 2024"},{"issue":"12","key":"2024080102534014000_B108","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1182\/bloodadvances.2022007004","article-title":"Fertility testing knowledge and attitudes in male adolescents and young adults with SCD and their caregivers: a pilot study","volume":"6","author":"Nahata","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"2024080102534014000_B109","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/hematology.2019000039","article-title":"Complications in pregnant women with sickle cell disease","volume":"2019","author":"Smith-Whitley","year":"2019","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"5","key":"2024080102534014000_B110","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/trf.13418","article-title":"High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program","volume":"56","author":"McLaughlin","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"2024080102534014000_B111","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/pbc.24459","article-title":"Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs","volume":"60","author":"Blinder","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2024080102534014000_B112","doi-asserted-by":"crossref","first-page":"e20182587","DOI":"10.1542\/peds.2018-2587","article-title":"Supporting the health care transition from adolescence to adulthood in the medical home","volume":"142","author":"White","year":"2018","journal-title":"Pediatrics"},{"key":"2024080102534014000_B113","unstructured":"Centers for Disease Control and Prevention. Steps to better health for people with sickle cell disease toolkit. Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/betterhealthtoolkit\/index.html. Accessed February 23, 2024"},{"issue":"6","key":"2024080102534014000_B114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1043454215591954","article-title":"APHON\/ASPHO Policy statement for the transition of patients with sickle cell disease from pediatric to adult health care","volume":"32","author":"Bryant","year":"2015","journal-title":"J Pediatr Oncol Nurs"},{"issue":"5","key":"2024080102534014000_B115","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1542\/peds.2011-3049","article-title":"Transition and sickle cell disease","volume":"130","author":"DeBaun","year":"2012","journal-title":"Pediatrics"},{"key":"2024080102534014000_B116","unstructured":"St. Jude Children\u2019s Research Hospital. Sickle cell transition e-learning program. Available at: https:\/\/www.stjude.org\/treatment\/disease\/sickle-cell-disease\/step-program.html. Accessed February 23, 2024"},{"key":"2024080102534014000_B117","unstructured":"The National Alliance to Advance Adolescent Health. Got Transition? Available at: www.gottransition.org. Accessed February 23, 2024"},{"key":"2024080102534014000_B118","unstructured":"Centers for Disease Control and Prevention. Taking charge of your health and health care. Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/features\/sickle-cell-transition.html. Accessed February 23, 2024"},{"key":"2024080102534014000_B119","unstructured":"American Society of Hematology. Pediatric to adult hematologic care transition. Available at: https:\/\/www.hematology.org\/education\/clinicians\/clinical-priorities\/pediatric-to-adult-care-transition. Accessed February 23, 2024"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-066842\/1685364\/peds.2024-066842.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2024-066842\/1685364\/peds.2024-066842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T03:03:12Z","timestamp":1722481392000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/154\/2\/e2024066842\/197803\/Health-Supervision-for-Children-and-Adolescents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":119,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,7,22]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2024-066842","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"article-number":"e2024066842"}}